birth control patch

FDA Panel Backs Benefit of Birth Control Patch
FDA Panel Backs Benefit of Birth Control Patch
FDA Panel Backs Benefit of Birth Control Patch
A panel of federal health advisers says Johnson & Johnson's Ortho Evra birth control patch remains a beneficial option for women seeking birth control, despite increasingly strong evidence that the drug carries a slightly higher risk of dangerous blood clots than older birth control pills.